Resultados de la búsqueda 301-310 of 14563 for the understanding and treatment of gynecological conditions
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...
... conditions. A Study to Compare 3- and 4-Part ... treatment. Multi-Center Prospective Validation ... The purpose of this study is to understand how ...
Mayo Clinic; 2022. Collee J, et al. Polycystic ovarian syndrome and infertility: Overview and insights of the putative treatments. Gynecological Endocrinology.
PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers ... Rochester, Minn. The purpose of this study is to determine the response ...
The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment ... conditions. A Study to Compare 3- and 4-Part ...
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel ...
Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment. Scottsdale/Phoenix, Ariz. The purpose of this study is to identify subtype ...
The purpose of this study is to establish a prospective, standardized data collection for the patients who undergo surgical treatment of progressive post- ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?